B019

フェノキシベンザミン 塩酸塩

≥97%, powder

• 別名: N-(2-クロロエチル)-N-(1-メチル-2-フェノキシエチル)-ベンジルアミン塩酸塩
• 実験式（ヒル表記法）: C₁₈H₂₂ClNO · HCl
• CAS番号: 63-92-3
• 分子量: 340.29
• NACRES: NA.77
• PubChem Substance ID: 24277760
• UNSPSC Code: 12352116
• EC Number: 200-569-7
• MDL number: MFCD00055152
• Assay: ≥97%
• Form: powder

特性

• Quality Segment: 100
• assay: ≥97%
• form: powder
• color: white
• solubility: H₂O: slightly soluble, alcohol: soluble, propylene glycol: soluble
• originator: Wellspring
• storage temp.: 2-8°C
• SMILES string: Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2
• InChI: 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H
• InChI key: VBCPVIWPDJVHAN-UHFFFAOYSA-N
• Gene Information: human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)

詳細

Biochem/physiol Actions

Calmodulin antagonist; α-adrenoceptor antagonist.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Wellspring. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全性情報

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H351
• pcodes: P201 - P301 + P312 + P330 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Carc. 2
• 保管分類: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges